[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Highest deaths since 1929", "description": "but they are now going down.\n\nUS omicron variants\n\nhttps://covid.cdc.gov/covid-data-tracker/#variant-proportions\n\nBA.2, 39%\nBA.2.12.1, 58%\nLess common omicron derivatives\nOthers, 0.1%\nDelta, 0%\n\nUK, covid symptom Zoe study\n\nONS\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections\n\nRisk of re-infection\n\nRisk of re-infection, eight times higher in Omicron times (20 December 2021 onwards), \n\ncompared with Delta times, (17 May to 19 December 2021)\n\nDeaths\n\nCOVID-19 is mentioned on fewer death certificates than flu and pneumonia\n\nBut, more likely to be listed as the underlying cause of death\n\nNumber of deaths due to COVID-19, and flu and pneumonia, England and Wales, 1901 to 2021\n\nCOVID-19, 2020\n\nUnderlying cause of 73,766 deaths\n\nCOVID-19, 2021\n\nUnderlying cause of 67,258 deaths\n\nDeaths due to flu and pneumonia, 1929 \n\nUnderlying cause of 73,212 deaths", "link": "https://www.youtube.com/watch?v=AVnjA_KNozs", "date_published": "2022-05-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "US Long Covid 20% of cases", "description": "Which is way higher than the UK figure\n\nCDC, Long covid \n\nLatest UK figures\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections\n\n2.8% of the population, self-reported\n\nOf those, \n\n73% symptoms at least 12 weeks\n\n44% symptoms at least one year\n\nPost\u2013COVID Conditions Among Adult COVID-19 Survivors Aged 18\u201364 and \u226565 Years \u2014 United States, March 2020\u2013November 2021\n\nhttps://www.cdc.gov/mmwr/volumes/71/wr/mm7121e1.htm?s_cid=mm7121e1_e&ACSTrackingID=USCDC_921-DM82414&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2071%2C%20May%2024%2C%202022&deliveryName=USCDC_921-DM82414#contribAff\n\nPreviously infected with SARS-CoV-2,\n\nreported persistent symptoms\n\n\u22654 weeks after acute COVID-19\n\nMarch 2020\u2013November 2021\n\nUnited States, aged \u226518\n\nIncidence of 26 conditions often / previously attributable to post-COVID\n\nAmong all patients aged \u226518 years\n\n38% of case-patients experienced an incident condition\n\n16% of controls\n\n18\u201364 years\n\n35.4% of case-patients experienced at least one incident condition\n\n14.6% of controls experienced at least one incident condition\n\nAged \u226565 years\n\n45.4% of case-patients experienced at least one incident condition\n\n18.5% of controls experienced at least one incident condition.\n\nSurvivors aged 18\u201364\n\nOne in 5\n\nSurvivors aged \u226565\n\nOne in 4\n\nexperiencing an incident condition that might be attributable to previous COVID-19\n\nConditions affected multiple systems\n\ncardiovascular, pulmonary, hematologic, renal, endocrine, gastrointestinal, musculoskeletal, neurologic, and psychiatric signs and symptoms\n\nHighest risk ratios (RRs)\n\nAcute pulmonary embolism\n\n18 to 64, RR = 2.1\n\n\u226565, RR = 2.1\n\nRR = 2.1 and 2.2 among persons aged 18\u201364 and \u226565 years, respectively) and \n\nRespiratory signs and symptoms\n\nRR = 2.1 in both age groups\n\nCritical to reducing the incidence and impact of post-COVID\n\nImplementation of COVID-19 prevention strategies\n\nRoutine assessment for post-COVID conditions\n\nis critical to reducing the incidence and impact of post-COVID\n\nThe research study\n\nA retrospective matched cohort design\n\nMarch 2020\u2013November 2021\n\n63.4 million unique adult records\n\n110 data contributors in the 50 states\n\nCase-patients, 353,164\nControl patients, 1,640,776\n\nCase-patients or control patients with a previous history of one of the included conditions were excluded\n\nNo significant difference\n\nCerebrovascular disease\n\nMental health conditions\n\nSubstance-related disorders\n\nDifferences by age group were noted\n\nRR for cardiac dysrhythmia\n\n18 to 64, RR = 1.7\n\n\u226565, RR = 1.5\n\nMusculoskeletal pain\n\n18\u201364, RR = 1.6\n\n\u226565, RR = 1.4\n\nRRs for 10 incident conditions, significantly higher among those aged \u226565\n\nRenal failure, thromboembolic events, cerebrovascular disease, type 2 diabetes, muscle disorders, neurologic conditions, and mental health conditions (including mood disorders, anxiety, other mental conditions, and substance-related disorders\n\nLimitations\n\nPatients infected with recent variants\n\nAcute COVID-19 infection might be biased toward a population that is seeking care\n\nCOVID-19 vaccination status was not considered in this analysis", "link": "https://www.youtube.com/watch?v=QnGnGAtKilk", "date_published": "2022-05-25 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]